Biotech · Private company
Jennerex Biotherapeutics
Track this companyFree. Adds Jennerex Biotherapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- Best Supportive CarePhase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- IrinotecanPhase 2 · Colorectal CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- JX-594Phase 2 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- JX-594Phase 2 · Colorectal CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- JX-594 recombinant vaccina GM-CSFPhase 2 · Hepatocellular CarinomaClinicalTrials.gov · fetched Nov 12, 2026
- JX-594 recombinant vaccina GM-CSFPhase 2 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- JX-594: Recombinant vaccinia virus (TK-deletion plus GM-CSF)Phase 2 · Carcinoma, HepatocellularClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Phase 2a Study of Modified Vaccinia Virus to Treat Sorafenib-naïve Advanced Liver CancerPHASE2 · COMPLETED · started Jun 1, 2012ClinicalTrials.gov NCT01636284 · fetched Nov 12, 2026
- Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal CarcinomaPHASE1_PHASE2 · COMPLETED · started Jan 1, 2012ClinicalTrials.gov NCT01394939 · fetched Nov 12, 2026
- A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed SorafenibPHASE2 · COMPLETED · started Oct 8, 2011ClinicalTrials.gov NCT01387555 · fetched Nov 12, 2026
- A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular CarcinomaPHASE2 · COMPLETED · started Aug 1, 2008ClinicalTrials.gov NCT00554372 · fetched Nov 12, 2026
- A Study of Recombinant Vaccinia Virus to Treat Malignant MelanomaPHASE1_PHASE2 · COMPLETED · started Feb 1, 2007ClinicalTrials.gov NCT00429312 · fetched Nov 12, 2026